Form 4 for LIMN Liminatus Pharma, Inc.
Accepted 2026-07-06 16:59:20 ET · period of report 2026-06-24 · accession 0001104659-26-080806 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-06 16:59 | 2026-06-24 | LIMN | Valetudo Therapeutics LLC | 10% | J - Other | — | -4.37M | 1.80M | -71% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2026-06-24 | J | D | 4,373,603 | — | 1,795,803 | D | — | — | (F2) The reported transaction involves a transfer of securities for which no payment of consideration was received. (F1) Consists of 1,795,803 shares of common stock held of record by Valetudo Therapeutics LLC ("Valetudo"). On June 24, 2026, Valetudo transferred 4,373,603 shares of common stock to Ewon Comfortech Co., Ltd and retains voting power over such shares pursuant to a voting agreement. Mr. Chris Kim is the CEO and controlling member of Valetudo and has voting and dispositive power over, and may be deemed to be the beneficial owner of, the shares held by Valetudo. The business address of Valetudo is 2251 Stern Goodman Street, Suite E, Fullerton, California 92833. Mr. Kim disclaims any beneficial ownership of any shares held by Valetudo except to the extent of his ultimate pecuniary interest therein. |